---
title: "Genesis MedTech announces sale of JC Medical to Edwards Lifesciences"
date: "2024-08-19T11:48:26.000Z"
publishedDate: "19 août 2024"
summary: "Genesis MedTech has sold JC Medical to Edwards Lifesciences, in a deal that includes the intellectual property and commercial rights of its J-Valve transcatheter aortic valve implantation (TAVI) system for the treatment of severe aortic regurgitation (AR). The transaction includes an upfront payment plus potential sales-based contingent milestones."
importance: ""
sourceUrl: "https://cardiovascularnews.com/genesis-medtech-edwards-lifesciences/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-08-19-genesis-medtech-announces-sale-of-jc-medical-to-edwards-lifesciences"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2019/01/j-valve.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/genesis-medtech-edwards-lifesciences/"
---

![Genesis MedTech announces sale of JC Medical to Edwards Lifesciences](https://cardiovascularnews.com/wp-content/uploads/sites/14/2019/01/j-valve.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/genesis-medtech-edwards-lifesciences/*

## L’essentiel

Genesis MedTech has sold JC Medical to Edwards Lifesciences, in a deal that includes the intellectual property and commercial rights of its J-Valve transcatheter aortic valve implantation (TAVI) system for the treatment of severe aortic regurgitation (AR). The transaction includes an upfront payment plus potential sales-based contingent milestones.

## Lien source

https://cardiovascularnews.com/genesis-medtech-edwards-lifesciences/
